| ²é¿´: 678 | »Ø¸´: 3 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
sunjing2008Òø³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú£¡ ÒÑÓÐ1È˲ÎÓë
|
|||
| ΢Æ×ÇóÖú»¯ºÏÎï½á¹¹£¡13C-NMR:203.9,170.1,162.7,159.3,156.2,139.5,127.5,110.8,103.9,102.5,79.4,74.8,72.0,44.9,42.6,42.5,38.6,32.0,27.6,26.7,22.7. |
» ²ÂÄãϲ»¶
309Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ÇóÉúÎïѧѧ˶µ÷¼Á¡ª¡ª364·Ö
ÒѾÓÐ3È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤
ÒѾÓÐ17È˻ظ´
359Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
0703×Ü·Ö331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼ÑÐÉúÎïѧ¿¼AÇø211£¬³õÊÔ322£¬¿ÆÄ¿Éú»¯ºÍÉúÎï×ۺϣ¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ28È˻ظ´

sunjing2008
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7873.6
- É¢½ð: 25
- ºì»¨: 1
- Ìû×Ó: 711
- ÔÚÏß: 104.2Сʱ
- ³æºÅ: 1342683
- ×¢²á: 2011-07-11
- ÐÔ±ð: MM
- רҵ: ÖÐÒ©ÖÆ¼Á

3Â¥2015-01-12 20:21:57
wangkaibo123
ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)
kerry
-

ר¼Ò¾Ñé: +726 - PhEPI: 3
- Ó¦Öú: 1928 (½²Ê¦)
- ¹ó±ö: 0.598
- ½ð±Ò: 7869.1
- É¢½ð: 10156
- ºì»¨: 100
- Ìû×Ó: 3780
- ÔÚÏß: 1007.1Сʱ
- ³æºÅ: 2088618
- ×¢²á: 2012-10-26
- ÐÔ±ð: GG
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
- ¹ÜϽ: ҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
sunjing2008: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-13 08:37:17
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
sunjing2008: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2015-01-13 08:37:17
|
ÈÏÕæµã£¬±ð¶àÁË·ûºÅ ²éѯģʽ£ºÄ£ºý²éѯ ̼Æ×Êý¾ÝÊäÈ룺 °´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 22.7,26.7,27.6,32.0,38.6,42.5,42.6,44.9,72.0,74.8,79.4,102.5,103.9,110.8,127.5,139.5,156.2,159.3,162.7,170.1,203.9 ÈܼÁÑ¡Ï È«²¿ CDCl3 CD3CD2OD CD2Cl2 C5D5N C3D7NO CD3SOCD3 C4D8O CD3COOD C4D8O2 D2O CF3COOD CD3OD CD3COCD3 C6D6 CD3CN ²éѯ¿ÕÖµ Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨) ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½38¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) -------------------------------------------------------------------------------- 1 . chrodrimanin E C25H30O6 ÏàËÆ¶È:84% Bioscience, Biotechnology, and Biochemistry 2012 76 1765-1768 New Chrodrimanin Congeners, Chrodrimanins D¨CH, from YO-2 of Talaromyces sp. Hideo HAYASHI, Yuki OKA, Kenji KAI, Kohki AKIYAMA Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 2 . chrodrimanin F C25H34O6 ÏàËÆ¶È:68% Bioscience, Biotechnology, and Biochemistry 2012 76 1765-1768 New Chrodrimanin Congeners, Chrodrimanins D¨CH, from YO-2 of Talaromyces sp. Hideo HAYASHI, Yuki OKA, Kenji KAI, Kohki AKIYAMA Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 3 . chrodrimanin D C25H32O7 ÏàËÆ¶È:60% Bioscience, Biotechnology, and Biochemistry 2012 76 1765-1768 New Chrodrimanin Congeners, Chrodrimanins D¨CH, from YO-2 of Talaromyces sp. Hideo HAYASHI, Yuki OKA, Kenji KAI, Kohki AKIYAMA Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 4 . clusiacyclol B C23H24O4 ÏàËÆ¶È:57.1% Phytochemistry 1995 38 485-489 Citrans and cyclols from Clusia multiflora Jaime Gonzalez Gonzalez, Eduardo Martinez Olivares, Franco Delle Monache Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 5 . (-)-7,8-dihydrocalanolide B C22H28O5 ÏàËÆ¶È:54.5% Journal of Medicinal Chemistry 1996 39 4507-4510 Structure−Activity Modifications of the HIV-1 Inhibitors (+)-Calanolide A and (− -Calanolide B1Deborah L. Galinis, Richard W. Fuller, Tawnya C. McKee, John H. Cardellina II, Robert J. Gulakowski, James B. McMahon, and Michael R. Boyd Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 6 . (-)-7,8-dihydro-12-oxocalanolide B C22H26O5 ÏàËÆ¶È:54.5% Journal of Medicinal Chemistry 1996 39 4507-4510 Structure−Activity Modifications of the HIV-1 Inhibitors (+)-Calanolide A and (− -Calanolide B1Deborah L. Galinis, Richard W. Fuller, Tawnya C. McKee, John H. Cardellina II, Robert J. Gulakowski, James B. McMahon, and Michael R. Boyd Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 7 . Leosibirone A C22H32O6 ÏàËÆ¶È:54.5% Journal of Natural Products 2011 74 831-836 Labdane Diterpenoids from Leonurus sibiricus Hankui Wu, Frank R. Fronczek, Daneel Ferreira, Charles L. Burandt, Jr, and Jordan K. Zjawiony Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 8 . 8,9-dihydro-5-hydroxy-6-(3-methylbutanoyl)-4-phenyl-8-(prop-1-en-2-yl)furo[2,3-h]chromen-2-one ÏàËÆ¶È:52.3% Phytochemistry 2004 65 2867-2879 4-Alkyl- and 4-phenylcoumarins from Mesua ferrea as promising multidrug resistant antibacterials Luisella Verotta , Erminio Lovaglio, Giovanni Vidari, Paola Vita Finzi,Maria Grazia Neri, Alessandro Raimondi, Silvia Parapini, Donatella Taramelli,Antonella Riva, Ezio Bombardelli Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 9 . agallochin N C21H32O5 ÏàËÆ¶È:52.3% Phytochemistry 2003 585-589 Seco diterpenoids from Excoecaria agallocha L. Ammanamanchi S.R. Anjaneyulu, Vadali Lakshmana Rao Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 10 . 10-deoxypatrinoside ÏàËÆ¶È:52.3% Planta Medica 1988 54 452-453 Iridoids from Penstemon richardsonii B. Gering-Ward and M. Wichtl Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 11 . 10-deoxypatrinoside ÏàËÆ¶È:52.3% Planta Medica 1988 54 452-453 Iridoids from Penstemon richardsonii B. Gering-Ward and M. Wichtl Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 12 . 10-desoxypatrinosid ÏàËÆ¶È:52.3% Planta Medica 1985 51 434-436 Hydrogenation of Iridoid Glucosides with Exocyclic Double Bond Peter Junior Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 13 . 3,17¦Â-Dihydroxy-19-norpregna-1,3,5(10)-triene-20-yne-6-one C20H22O3 ÏàËÆ¶È:52.3% Steroids 2002 67 165-174 Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references I. Victor Ekhato, Tim Hurley, Michael Lovdahl, T. J. Revitte, Luyi Guo, Yun Huang, Scott Clipper, Charles Colson Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 14 . 4',5,7-trihydroxy-6-methyl-8-(3-methyl-[2-butenyl])flavanone C21H22O5 ÏàËÆ¶È:52.3% Phytochemistry 1999 52 1469-1471 Antibacterial and antifungal flavanones from Eysenhardtia texana Gerald A. Wächter, Joseph J. Hoffmann, Todd Furbacher, Mary E. Blake, Barbara N. Timmermann Structure 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 15 . (4R)-3-(2-¦Â-D-glucopyranoxyloxy- 4-hydroxyphenyl)-4-(4-hydroxybenzyl) but-2-en-4-olide C23H24O10 ÏàËÆ¶È:52.3% Phytochemistry 1997 46 921-928 Phenolic glucosides from the root of Pueraria lobata Kazuhiro Hirakura, Makoto Morita, Kaoru Nakajima, Koh Sugama, Koji Takagi, Kazuaki Niitsu, Yukinobu Ikeya, Masao Maruno, Minoru Okada Structure 13C NMR ̼Æ×Ä£Äâͼ |

4Â¥2015-01-12 21:47:49














»Ø¸´´ËÂ¥
-Calanolide B1